Health Trials

Solar Lentigo

3

Review clinical trials related to Solar Lentigo. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Clinical Study to Evaluate the Efficacy in Improving Dark Spots After 8 Weeks of Use of Facial Sunscreens in Adult Participants

The study aims to evaluate the efficacy of a facial sunscreen under two experimental conditions-untinted and tinted-in improving facial spots (melasma and solar lentigines/post-inflammatory hyperpigmentation) after 8 weeks of product use under normal conditions by adult participants.

Participants needed: 152
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Kenvue Brands LLCUpdated: Jul 1, 2026Locations: 1
Eligibility criteria

Able to understand and follow study instructions [+5]

Known sensitivity or allergy to cosmetic or skincare products [+7]

Read more
Status: Not yet recruiting

Evaluation of Efficacy and Tolerabilty of MelaB3 Serum in Combination of 35% Glycolic Acid Peeling Compared to 35% Glycolic Acid Peeling Alone in Various Hyperpigmentation Conditions

Randomized clinical trial to assess the effectiveness and tolerability of Mela B3 serum in combination with 35% glycolic acid peel vs. 35% glycolic acid peel for the treatment of various hyperpigmentation conditions (melasma, post-inflammatory hyperpigmentation and solar lentigo) and signs of aging in a population of participants from the Autonomous City of Buenos Aires, Argentina.

Participants needed: 80
Trial details
Age: 30-70Biological sex: AllType: InterventionalSponsor: Cosmetique Active InternationalUpdated: Feb 24, 2026
Eligibility criteria

Women and men [+9]

Pregnant, breastfeeding or with pregnancy plans. [+18]

Read more
Status: Not yet recruiting

CLINICAL INVESTIGATION TO EVALUATE THE EFFICACY AND SAFETY OF EPILADY PROTOTYPE DEVICE FOLLOWED BY APPLICATION OF A TOPICAL FORMULA ON DEPIGMENTATION OF LENTIGO SPOTS

To assess the efficacy of the Epilady investigational device, used with and without a topical depigmenting formula, in reducing the appearance of lentigo spots on the hands and forearms of healthy female participants over an 84-day period

Participants needed: 44
Trial details
Age: 35-70Biological sex: FemaleType: InterventionalSponsor: Cosmetique Active InternationalUpdated: Nov 20, 2025Locations: 1
Eligibility criteria

Healthy female participants aged between 35 and 70 years old at the time of incl... [+7]

• Participants with dry or sensitive skin, as assessed by the investigator. [+16]

Read more